Clinical Trial Update: Phase II Clinical Trial of KJ101in the Treatment of Deep II Degree Burns [Phase 2]

View source ↗

Summary

Phase II clinical trial update for KJ101 in the treatment of deep second-degree burns. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burns

Drugs mentioned

• KJ101

Snippet

Sponsor: Shanghai Bao Pharmaceuticals Co., Ltd. | Conditions: Burn, Burn Wounds - Partial Thickness (2nd Degree) | Phase 2 | Status: RECRUITING